BARBI, Stefano
 Distribuzione geografica
Continente #
EU - Europa 1570
NA - Nord America 1351
AS - Asia 511
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 3437
Nazione #
US - Stati Uniti d'America 1343
GB - Regno Unito 721
CN - Cina 466
IT - Italia 275
SE - Svezia 127
FR - Francia 124
IE - Irlanda 105
DE - Germania 73
FI - Finlandia 64
UA - Ucraina 31
BE - Belgio 21
VN - Vietnam 19
RU - Federazione Russa 17
IR - Iran 10
TR - Turchia 10
CA - Canada 5
ES - Italia 3
NL - Olanda 3
CH - Svizzera 2
IL - Israele 2
IN - India 2
MX - Messico 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HK - Hong Kong 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 3437
Città #
Southend 687
Chandler 354
Jacksonville 260
Ann Arbor 169
Woodbridge 141
Dublin 105
Houston 89
Beijing 66
Verona 57
Shenyang 56
Nanjing 51
Jinan 48
Lawrence 43
Princeton 43
Wilmington 41
Hebei 35
Tianjin 28
Ningbo 22
Brussels 21
Changsha 21
Ashburn 20
Nanchang 19
Rome 16
Guangzhou 15
Zhengzhou 15
Haikou 14
Jiaxing 13
Taiyuan 13
Fairfield 11
Taizhou 11
Dearborn 10
Hangzhou 10
Redmond 10
Bologna 9
Milan 8
Dong Ket 7
Fuzhou 7
Norwalk 7
Boardman 5
Falls Church 5
Ardabil 4
Augusta 4
Bolzano 4
Lancaster 4
Lanzhou 4
Los Angeles 4
Redwood City 4
Corbetta 3
Kemerovo 3
Monmouth Junction 3
Palermo 3
Quarto D'altino 3
San Francisco 3
Toronto 3
Auburn Hills 2
Cerea 2
Chicago 2
Costa Mesa 2
Ferrara 2
Groningen 2
Latina 2
Leawood 2
Mestre 2
New York 2
Novokuznetsk 2
Nürnberg 2
Piemonte 2
Qingdao 2
Roverbella 2
Saronno 2
Toledo 2
Torino 2
Trieste 2
Winnipeg 2
Zanjan 2
Ameglia 1
Azzano Decimo 1
Baranzate 1
Cairo 1
Capriate San Gervasio 1
Caserta 1
Castelnuovo 1
Central 1
Cernobbio 1
Cesena 1
Cosenza 1
Crespellano 1
Crotone 1
Düsseldorf 1
Easton 1
Fiorano Modenese 1
Genova 1
Hefei 1
Kharkov 1
Melbourne 1
Mexico City 1
Minsk 1
Montegaldella 1
Morrovalle 1
Mumbai 1
Totale 2678
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 270
Whole-genome landscape of pancreatic neuroendocrine tumours 138
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 125
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 119
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 117
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 115
Reporting tumor molecular heterogeneity in histopathological diagnosis 105
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 98
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 98
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 88
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 85
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 82
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 82
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphoma 81
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis 80
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 79
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 79
Chromosome 3p alterations in pancreatic endocrine neoplasia 78
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 76
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen 75
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 74
Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway 73
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas 73
Molecular biology of neuroendocrine tumors 73
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 72
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 71
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 68
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 67
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 67
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 64
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 64
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 64
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 63
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 63
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 61
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 61
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 58
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 58
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 56
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 55
Mutazionidi PI3KCA nel cancro gastrico 47
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 38
Wnt (canonical and non canonical) pathways in breast carcinoma with extensive vascular invasion and inflammatory breast carcinoma 24
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 3
Totale 3487
Categoria #
all - tutte 5696
article - articoli 4332
book - libri 0
conference - conferenze 1076
curatela - curatele 0
other - altro 174
patent - brevetti 0
selected - selezionate 0
volume - volumi 114
Totale 11392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018190 0000 00 6075 222067
2018/2019371 21486028 1956 5517 423031
2019/2020567 55232640 4466 6348 24545173
2020/2021556 70864474 8536 1236 2485229
2021/2022438 37175535 178 419 1763283
2022/2023730 6412086145 82220 130 0000
Totale 3487